Page 6 - Viking Therapeutic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cutting-Edge Biotech: A Novel Gene Therapy That Reverses Aging and a New Oral GLP-1 Drug From Viking Therapeutics

Viking Therapeutics' GLP-1 drug is able to induce an average weight loss of 14.7% of the body weight after just 13 weeks of treatment.

Jing liangNovo nordiskZealand amylinEli lillyCompany retatutideGoldman sachsViking therapeuticsGlucose dependent insulinotropic polypeptideViking therapeuticZealand pharmaWall st engineWall streetNew gene therapyExtend humanReverses age related changesCarolina cano macip

Viking Therapeutic s (VKTX) Obesity Data Seen as Impressive

Viking Therapeutic s (VKTX) Obesity Data Seen as Impressive
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Joon leeEli lilly coTruist securitiesViking therapeuticRivals novo nordiskEli lilly

Viking Therapeutic (VKTX) PT Raised to $80 at Stifel, Best-in-Class Profile of Injectable VK2735 Stands Firm

Viking Therapeutic (VKTX) PT Raised to $80 at Stifel, Best-in-Class Profile of Injectable VK2735 Stands Firm
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Samimy annabelViking therapeutic

Europe: Stoxx 600 rises on miners, tech support; German shares at record high

Europe: Stoxx 600 rises on miners, tech support; German shares at record high
businesstimes.com.sg - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstimes.com.sg Daily Mail and Mail on Sunday newspapers.

Erik thedeenSteve sosnickZealand pharmaEuropean central bankNovo nordiskCentral bankRiksbank governor erik thedeenViking therapeuticEurofins scientificPeugeot invest

William Blair Comments on Viking Therapeutics, Inc s Q1 2024 Earnings (NASDAQ:VKTX)

Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Analysts at William Blair lowered their Q1 2024 earnings per share estimates for Viking Therapeutics in a research report issued to clients and investors on Wednesday, February 7th. William Blair analyst A. Hsieh now expects that the biotechnology company will post earnings per share of ($0.27) for […]

Greg zanteWilliam blairSarah kathryn rouanTherapeutics company profileVanguard group incTherapeutics incBalyasny asset managementMaxim groupBlackrock incSecurities exchange commissionViking therapeuticsFree reportViking therapeuticTruist financialTherapeutics stock downGet free report